The table below shows Candel Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$125.00K
$125.00K
$125.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$30.50M
$19.31M
$24.51M
$20.79M
$15.18M
$8.75M
SG&A
$17.77M
CADL annual revenue (10-K history)
Candel Therapeutics, Inc. reported annual revenue of $125.00K for fiscal year 2022. That is up 0.0% from $125.00K in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.